Reste-t-il une place pour la chimiothérapie dans les cancers broncho-pulmonaires porteurs d'une altération moléculaire addictive ? Les arguments du non

With the emergence of molecular targeted therapies in the management of non-small cell lung cancer, the role of conventional chemotherapy can be questioned. This article presents the key arguments against the use of cytotoxics in presence of a targetable alteration.